CTMS Market Growth to 2030 Led by CRO and Cloud Adoption as the Global Industry is set to Expand at 14.89%, says Mordor Intelligence
Growth in the clinical trial management system market is being driven by digital transformation in pharmaceutical R&D, cloud-deployment trends, demands for real-time oversight, and increasing trial complexity.
Hyderabad, India, Nov. 04, 2025 (GLOBE NEWSWIRE) — According to Mordor Intelligence, the global clinical trial management systems market is valued at USD 2.44 billion in 2025. It is projected to surpass USD 4.89 billion by 2030, expanding at a CAGR of 14.89 % over the period. The acceleration is attributed to rising digital maturity among sponsors, contract research organizations (CROs), and stricter regulatory transparency mandates.
Geographical Insights
- North America currently holds the largest share of the CTMS market, supported by a dense network of pharmaceutical sponsors, experienced investigator sites, and predictable regulatory frameworks.
- Asia-Pacific is projected to register the fastest growth, driven by regulatory reforms in China and India and expanding local trial volumes.
Emerging Key Trends
Rising Complexity of Clinical Trials: Multi-site, multi-arm, and global trials require centralized platforms for planning, monitoring, and reporting, driving demand for CTMS solutions.
Integration with Real-World Data and EHRs: Linking clinical trial management systems with electronic health records and real-world data sources improves patient recruitment, monitoring, and endpoint analysis.
AI and Analytics Adoption: Embedded analytics in CTMS platforms help predict patient dropouts, optimize trial design, and improve operational decision-making.
Pressure to Reduce Time-to-Market: Sponsors adopt CTMS solutions to streamline workflows, identify enrollment delays early, and optimize resource allocation, shortening trial timelines.
Overview of Market Segments
By Delivery Mode
- On-Premise
- Cloud-Based
- Hybrid / Hosted Private Cloud
By Component
- Software
- Services
By Type
- Enterprise-Wide CTMS
- Site CTMS
- eClinical Platform-Integrated CTMS
By Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV / Post-Marketing
By End User
- Pharmaceutical and Biotechnological Companies
- Medical Device Manufacturers
- Contract Research Organizations (CROs)
- Other End Users
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/global-clinical-trial-management-system-industry?utm_source=globenewswire
Competition Outlook
The market is moderately consolidated, with major CTMS players such as Oracle Corporation, Veeva Systems, and Medidata Solutions (a part of Dassault Systèmes) leading the field. These vendors are leveraging acquisitions, broader platform capabilities, and AI analytics integration to meet sponsors’ evolving needs.
- Oracle Corp.
- Dassault Systèmes (Medidata)
- Veeva Systems
- IBM Corp.
- Advarra
Check out related reports published by Mordor Intelligence:
EClinical Solutions Market: The eclinical solutions market report segments the industry by product (electronic clinical outcome assessment), by delivery mode (cloud-based), clinical trial phase (phase I, phase III), by end user (pharmaceutical and biotechnology companies), and geography.
Oracle Corporation, Veeva Systems, Mednet Solutions, PAREXEL International (Calyx), and Saama Technologies, Inc. are the major companies operating in this market.
Read more about companies active in EClinical Solutions: https://www.mordorintelligence.com/industry-reports/global-eclinical-solutions-market/companies?utm_source=globenewswire
Clinical Decision Support Systems Market: The clinical decision support systems market report segments the industry by model (knowledge-based CDSS, non-knowledge CDSS), by mode of delivery (cloud-based, on-premise), by component (hardware, software, services), by product (integrated CDSS, standalone CDSS), by application (medical diagnosis, alerts and reminders, prescription decision support), and geography (North America, Europe, Asia-Pacific).
Siemens Healthcare, Koninklijke Philips NV, Change Healthcare, IBM Corporation, and Oracle are the major companies operating in this market.
Read more about companies active in Clinical Decision Support Systems: https://www.mordorintelligence.com/industry-reports/clinical-decision-support-systems-market/companies?utm_source=globenewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
CONTACT: For any inquiries, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.